Table 5.
Responses after Mel280 or Mel200
| Melphalan 280 | Melphalan 200 | |
|---|---|---|
| N=66 | N=65 | |
| CR | 8 | 7 |
| nCR | 18 | 7 |
| nCR + CR | 26 (39.4%) | 14 (21.5%) |
| PR | 23 | 22 |
| nCR + CR + PR | 49 (74.2%) | 37 (56.9%) |
| MR | 1 | 9 |
| SD | 14 | 16 |
| PD | 2 | 3 |
Responses after Mel280 or Mel200
| Melphalan 280 | Melphalan 200 | |
|---|---|---|
| N=66 | N=65 | |
| CR | 8 | 7 |
| nCR | 18 | 7 |
| nCR + CR | 26 (39.4%) | 14 (21.5%) |
| PR | 23 | 22 |
| nCR + CR + PR | 49 (74.2%) | 37 (56.9%) |
| MR | 1 | 9 |
| SD | 14 | 16 |
| PD | 2 | 3 |